                               SEQUENCE LISTING

<110> THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
 
<120> IMPROVED HIGHLY POTENT SPECIFIC HUMAN KUNITZ INHIBITOR OF 
      FIBRINOLYTIC ENZYME PLASMIN

<130> 30435.0387WOU1

<140> PCT/US2021/049284
<141> 2021-09-07

<150> 63/112,840
<151> 2020-11-12

<150> 63/076,516
<151> 2020-09-10

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 60
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Asn Ala Glu Ile Cys Leu Leu Pro Leu Asp Thr Gly Pro Cys Lys Ala 
1               5                   10                  15      


Arg Leu Leu Arg Tyr Tyr Tyr Asp Arg Tyr Thr Gln Ser Cys Arg Gln 
            20                  25                  30          


Phe Leu Tyr Gly Gly Cys Glu Gly Asn Ala Asn Asn Phe Tyr Thr Trp 
        35                  40                  45              


Glu Ala Cys Asp Asp Ala Cys Trp Arg Ile Glu Lys 
    50                  55                  60  


<210> 2
<211> 180
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 2
aacgcggaga tctgtctcct gcccctagac accggaccct gcaaagccag acttctccgt       60

tactactacg acaggtacac gcagagctgc cgccagttcc tgtacggggg ctgcgagggc      120

aacgccaaca atttctacac ctgggaggct tgcgacgatg cttgctggag gatagaaaaa      180


<210> 3
<211> 73
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 3
Asp Ala Ala Gln Glu Pro Thr Gly Asn Asn Ala Glu Ile Cys Leu Leu 
1               5                   10                  15      


Pro Leu Asp Tyr Gly Pro Cys Arg Ala Leu Leu Leu Arg Tyr Tyr Tyr 
            20                  25                  30          


Asp Arg Tyr Thr Gln Ser Cys Arg Gln Phe Leu Tyr Gly Gly Cys Glu 
        35                  40                  45              


Gly Asn Ala Asn Asn Phe Tyr Thr Trp Glu Ala Cys Asp Asp Ala Cys 
    50                  55                  60                  


Trp Arg Ile Glu Lys Val Pro Lys Val 
65                  70              


<210> 4
<211> 80
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 4
Met Gly Ser Ser His His His His His His Ser Ser Gly His Ile Asp 
1               5                   10                  15      


Asp Asp Asp Lys Asn Ala Glu Ile Cys Leu Leu Pro Leu Asp Tyr Gly 
            20                  25                  30          


Pro Cys Arg Ala Arg Leu Leu Arg Tyr Tyr Tyr Asp Arg Tyr Thr Gln 
        35                  40                  45              


Ser Cys Arg Gln Phe Leu Tyr Gly Gly Cys Glu Gly Asn Ala Asn Asn 
    50                  55                  60                  


Phe Tyr Thr Trp Glu Ala Cys Asp Asp Ala Cys Trp Arg Ile Glu Lys 
65                  70                  75                  80  


<210> 5
<211> 80
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 5
Met Gly Ser Ser His His His His His His Ser Ser Gly His Ile Asp 
1               5                   10                  15      


Asp Asp Asp Lys Asn Ala Glu Ile Cys Leu Leu Pro Leu Asp Thr Gly 
            20                  25                  30          


Pro Cys Arg Ala Arg Leu Leu Arg Tyr Tyr Tyr Asp Arg Tyr Thr Gln 
        35                  40                  45              


Ser Cys Arg Gln Phe Leu Tyr Gly Gly Cys Glu Gly Asn Ala Asn Asn 
    50                  55                  60                  


Phe Tyr Thr Trp Glu Ala Cys Asp Asp Ala Cys Trp Arg Ile Glu Lys 
65                  70                  75                  80  


<210> 6
<211> 60
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 6
Asn Ala Glu Ile Cys Leu Leu Pro Leu Asp Thr Gly Pro Cys Arg Ala 
1               5                   10                  15      


Arg Leu Leu Arg Tyr Tyr Tyr Asp Arg Tyr Thr Gln Ser Cys Arg Gln 
            20                  25                  30          


Phe Leu Tyr Gly Gly Cys Glu Gly Asn Ala Asn Asn Phe Tyr Thr Trp 
        35                  40                  45              


Glu Ala Cys Asp Asp Ala Cys Trp Arg Ile Glu Lys 
    50                  55                  60  


